LY03003
Showing 1 - 13 of 13
Parkinson Disease Trial in Baltimore (LY03003, Neupro 4Mg/24Hr Transdermal Patch)
Completed
- Parkinson Disease
- LY03003
- Neupro 4Mg/24Hr Transdermal Patch
-
Baltimore, MarylandPharmaron CPC, Inc.
Mar 31, 2021
Parkinson Disease Trial (LY03003)
Completed
- Parkinson Disease
- LY03003
- (no location specified)
Nov 11, 2020
Parkinson Disease Trial in Beijing (LY03003)
Recruiting
- Parkinson Disease
- LY03003
-
Beijing, ChinaXuanwu Hospital Capital Medical University
Nov 13, 2020
Parkinson Disease Trial in Shenyang (LY03003, Placebo)
Completed
- Parkinson Disease
- LY03003
- Placebo
-
Shenyang, ChinaShengjing Hospital of China Medical University
Nov 13, 2020
Parkinson Disease Trial in Beijing (LY03003(Rotigotine,extended-release microspheres), Placebo,extended-release microspheres)
Unknown status
- Parkinson Disease
- LY03003(Rotigotine,extended-release microspheres)
- Placebo,extended-release microspheres
-
Beijing, ChinaXuanwu Hospital Capital Medical University
Sep 25, 2020
Parkinson Disease Trial in Beijing, Shenyang (LY03003 ( Rotigotine, extended-release microspheres), Placebo, extended-release
Completed
- Parkinson Disease
- LY03003 ( Rotigotine, extended-release microspheres)
- Placebo, extended-release microspheres
-
Beijing, China
- +2 more
Sep 21, 2020
Parkinson Disease Trial in Salt Lake City (LY03003 (rotigotine extended release microspheres for intramuscular [IM] injection),
Completed
- Parkinson Disease
- LY03003 (rotigotine extended release microspheres for intramuscular [IM] injection)
- Neupro 4 mg / 24 Hr. Transdermal Patch
-
Salt Lake City, UtahPharmaceutical Research Associates, Inc.
Oct 13, 2020
Parkinson's Disease Trial in Beijing (LY03003( the name of rotigotine), Placebo)
Completed
- Parkinson's Disease
- LY03003( the name of rotigotine)
- Placebo
-
Beijing, ChinaPeking University Third Hospital
Jul 1, 2020
Parkinson Disease Trial (Rotigotine, extended-release microspheres, Placebo, extended-release microspheres)
Completed
- Parkinson Disease
- Rotigotine, extended-release microspheres
- Placebo, extended-release microspheres
- (no location specified)
Aug 2, 2019
Parkinson Disease Trial in Hallandale Beach, Atlanta (LY03003)
Completed
- Parkinson Disease
- LY03003
-
Hallandale Beach, Florida
- +1 more
Nov 6, 2018
Cardiovascular Disease, Diabetes, Type 2 Trial in Worldwide (Dulaglutide, Placebo)
Completed
- Cardiovascular Disease
- Diabetes Mellitus, Type 2
- Dulaglutide
- Placebo
-
Mobile, Alabama
- +300 more
Sep 18, 2019